PND6 COST-EFFECTIVENESS OF GLATIRAMER ACETATE AND NATALIZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE PRESENCE OF LONG-TERM CLINICAL EVIDENCE
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65344-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)65344-2/fulltext
Title :
PND6 COST-EFFECTIVENESS OF GLATIRAMER ACETATE AND NATALIZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE PRESENCE OF LONG-TERM CLINICAL EVIDENCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65344-2&doi=10.1016/S1098-3015(10)65344-2
First page :
Section Title :
Open access? :
No
Section Order :
503